索拉非尼
Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
500 mg 1 g
Product Availability
In-stock
Price
$126.00
Member price
Product Availability
In-stock
Price
$188.00
Member price
Quantity
- +
Product Overview
Product Name Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base
CAS284461-73-0
FormulaC21H16ClF3N4O3
MW464.82
AppearanceWhite to off-white powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

Sorafenib (BAY549085; BAY-549085; BAY439006; BAY-439006; Nexavar; SFN) an approved anticancer medication, is a potent and orally bioavailable multikinase inhibitor with potential anticancer activity (BAY549085; BAY-549085; BAY439006; BAY-439006; Nexavar; SFN). In enzymatic assays, it inhibits numerous kinases, including Raf-1, B-Raf, and VEGFR-2, with IC50 values of 6 nM, 22 nM, and 90 nM, respectively. The FDA granted sorafenib approval in 2005 to treat advanced renal cancer.

Related literature
Related
Sorry, no related items
History
Tivozanib (AV-951)
Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base
Eflornithine Hydrochloride Monohydrate
ABT-888(Veliparib)
(E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile;Rilpivirine
PNU-159682 (Synonyms: PNU 159682)
Anti-Human CD4 Monoclonal Antibody(Ibalizumab)
Tixagevimab (Synonyms: AZD8895)
Apigenin-7-glucoside
Glecaprevir | ABT-493 | A 1282576